ClinicalTrials.gov
ClinicalTrials.gov Menu

mTor-inhibitor (EVERolimus) Based Immunosuppressive Strategies for CNI Minimisation in OLD for Old Renal Transplantation (EVEROLD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01028092
Recruitment Status : Completed
First Posted : December 9, 2009
Last Update Posted : July 8, 2014
Sponsor:
Collaborators:
Novartis
Roche Pharma AG
Genzyme, a Sanofi Company
Ministry of Health, France
Information provided by (Responsible Party):
University Hospital, Brest

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 2014
  Actual Study Completion Date : July 2014